How much are patients willing to pay to avoid postoperative nausea and vomiting?

@article{Gan2001HowMA,
  title={How much are patients willing to pay to avoid postoperative nausea and vomiting?},
  author={Tong J. Gan and Frank A. Sloan and Guy de L. Dear and Habib E. El-Moalem and David A Lubarsky},
  journal={Anesthesia and analgesia},
  year={2001},
  volume={92 2},
  pages={
          393-400
        }
}
Postoperative nausea and vomiting (PONV) are unpleasant experiences. However, there is no drug that is completely effective in preventing PONV. Whereas cost effectiveness analyses rely on specific health outcomes (e.g., years of life saved), cost-benefit analyses assess the cost and benefit of medical therapy in terms of dollars. We hypothesized that patients were willing to pay for a hypothetical new drug that would eliminate PONV. Eighty elective day surgical patients using general anesthesia… 
View on PubMed
doi.org
204 Citations
Highly Influential Citations
8
Background Citations
44
Methods Citations
1
Results Citations
3

204 Citations

Citation Type

Citation Type

Effect of Postoperative Experiences on Willingness to Pay to Avoid Postoperative Pain, Nausea, and Vomiting
TLDR
Prevention of postoperative pain was valued higher than prevention of PONV, and the elicited WTP values were lower than those reported in previous studies, which is possibly related to differences in market culture or patients' attitudes toward postoperativePain, nausea and vomiting.
Is postoperative nausea and vomiting still the big "little" problem?
  • S. Choi
  • Medicine
    Korean journal of anesthesiology
  • 2016
TLDR
This study demonstrated that a single bolus administration of fentanyl during anesthesia induction increased the incidence of PONV, while an intraoperative remifentanil infusion did not affect the incidence and severity of PonV.
Guideline for the management of postoperative nausea and vomiting.
Postoperative nausea and vomiting--can it be eliminated?
TLDR
Although PONV is rarely fatal, it is an unpleasant postoperative symptom (BOX), and even mild PonV can delay hospital discharge, decrease patient satisfaction, and increase use of resources.
General multimodal or scheduled risk-adopted postoperative nausea and vomiting prevention: just splitting hairs?
  • P. Kranke
  • Medicine
    British journal of anaesthesia
  • 2015
TLDR
All patients might benefit from 3 or more antiemetics during the course of surgery to reduce the incidence of PONV as much as possible, and Phil Scuderi’s statement with the title ‘Multimodal antiemetic management prevents early postoperative vomiting after outpatient laparoscopy’ is suggested.
Update on the management of postoperative nausea and vomiting and postdischarge nausea and vomiting in ambulatory surgery.
Possibilities and limitations in the pharmacological management of postoperative nausea and vomiting
TLDR
The low cost of most of the currently available antiemetics and the low incidence of side-effects suggests that a liberal antiemetic prophylaxis regimen is a meaningful option in order to eliminate or substantially reduce the ‘big little problem’.
The willingness of patients to pay for intravenous patient-controlled analgesia in Korea
TLDR
The satisfaction of IV-PCA increased patients' willingness to pay (WTP) after surgery, but the WTP may be independent of patient characteristics in Korea.
[Postoperative nausea and vomiting].
A Korean Predictive Model for Postoperative Nausea and Vomiting
TLDR
A case-controlled study to identify the risk factors for PONV in 5,272 surgical patients and found female, history of previous PonV or motion sickness, duration of anesthesia more than 1 hour, non-smoking status, and use of opioid in the form of patient controlled analgesia (PCA) were highly predictive.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 23 REFERENCES
Which clinical anesthesia outcomes are important to avoid? The perspective of patients.
TLDR
Avoiding nausea/vomiting, incisional pain, and gagging on the endotracheal tube was a high priority for most patients, and whether clinicians can improve the quality of anesthesia by designing anesthesia regimens that most closely meet each individual patient's preferences for clinical outcomes deserves further study.
Assessing the Willingness of Parents to Pay for Reducing Postoperative Emesis in Children
  • L. Diez
  • Medicine
    PharmacoEconomics
  • 2012
TLDR
It is found that simple cost—effectiveness studies of antiemetic agents including only direct costs underestimate the true value of the intervention.
Risk Reduction From Low Osmolality Contrast Media: What Do Patients Think It is Worth?
TLDR
Assessment of patient valuations of a particular new technology, low osmolality contrast media, concludes that similar WTP surveys may be helpful in addressing other difficult cost-quality issues.
The Effect of Timing of Ondansetron Administration on Its Efficacy, Cost-Effectiveness, and Cost-Benefit as a Prophylactic Antiemetic in the Ambulatory Setting
TLDR
Ondansetron 4 mg IV administered immediately before the end of surgery was the most efficacious in preventing postoperative nausea and vomiting, facilitating both early and late recovery, and improving patient satisfaction after outpatient laparoscopy.
Double-blind comparison of ondansetron, droperidol and saline in the prevention of postoperative nausea and vomiting.
TLDR
Both ondansetron and droperidol were superior to saline in preventing vomitingAlthough there was no significant difference between them, Metoclopramide, the rescue antiemetric, was demanded by 38%, 34% and 17% of patients receiving saline, droperIDol and ondANSetron.
Patients' assessment of ambulatory anesthesia and surgery.
  • B. Philip
  • Medicine
    Journal of clinical anesthesia
  • 1992
Double-blind, Randomized Comparison of Ondansetron and Intraoperative Propofol to Prevent Postoperative Nausea And Vomiting
TLDR
Propofol administered to induce and maintain anesthesia is more effective than ondansetron (with thiopental-isoflurane anesthesia) in preventing postoperative vomiting and is associated with fewer requests for rescue antiemetic and sedation in the early phase of recovery.
A clinician's guide to cost-effectiveness analysis.
TLDR
Because clinicians should participate in policy making, they must understand the role of this technique in setting funding priorities and demonstrate the consequences of allocation decisions.
Weights for Scoring the Quality of Well-being Instrument Among Rheumatoid Arthritics: A Comparison to General Population Weights
TLDR
The investigators believe that the study supports the use of the original general population weights and suggest that the index may be used for populations with a specific condition as well as for general populations.
Alternative approaches to valuing intangible health losses: the evidence for multiple sclerosis.
...
1
2
3
...